Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
Lancet
; 386(10011): 2404-12, 2015 Dec 12.
Article
in En
| MEDLINE
| ID: mdl-26423182
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Depressive Disorder, Treatment-Resistant
/
Aripiprazole
/
Antidepressive Agents
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet
Year:
2015
Type:
Article